Medmix.Header.SkipLinkLabel

News

medmix publishes a midyear report as well as an annual reports.

news 1150x540
Selected Filter: Show all

CURRENT NEWS

CURRENT NEWS

The unseen technology behind modern healthcare

In a feature published in the latest FOKUS "Future of Healthcare" publication, a special supplement to Finanz und Wirtschaft, medmix explores how expertise in mixing, dosing and precision delivery can be applied across different applications, creating new opportunities for healthcare innovation.

29 October 2026

medmix reaches 10 million parts milestone with sustainable Shadow Printing technology

medmix has produced 10 million parts using Shadow Printing, now in production at all three Beauty sites in Germany, the USA, and Brazil. The milestone reflects growing demand from cosmetics brands for packaging that combines premium aesthetics with greater sustainability.

28 October 2026

medmix launches MIXPAC™ PiccoMix™ to advance efficiency and sustainability in dental cementation delivery

medmix introduces the new MIXPAC™ PiccoMix™ mixing tip, a next-generation solution for dental cementation delivery designed to help dental professionals achieve more efficient material use, improved performance and reduced waste

13 October 2026

medmix secures second consecutive CDP "A" rating for Supplier Engagement

medmix has secured an "A" rating in CDP's Supplier Engagement Assessment for the second consecutive year

15 September 2026

medmix’ Drug Delivery (“Haselmeier”) to support the development of Xeris Pharmaceuticals’ XP-8121 with D-Flex™ pen injector

medmix’ Drug Delivery (“Haselmeier”) to support the development of Xeris Pharmaceuticals’ XP-8121 with D-Flex™ pen injector

10 September 2026

medmix Half-Year 2026 Results

Ad hoc announcement pursuant to Art. 53 LR

medmix strengthens profitability and cash flow while advancing growth and efficiency initiatives

23 July 2026

medmix strengthens its innovation portfolio with the launch of FleXa™

medmix introduces FleXa™, a new customizable syringe platform that advances precision and branding for single-component dental materials.

9 July 2026

medmix’ shareholders approve all proposals at annual general meeting 2026

At today’s annual general meeting (AGM) of medmix Ltd., shareholders approved all proposals of the Board of Directors. medmix will pay an ordinary dividend of CHF 0.10 per share.

16 April 2026

TIME names medmix as one of “World's Best Companies for Sustainable Growth 2026”

medmix has been included in the 2026 edition of the “World’s Best Companies in Sustainable Growth”, a global ranking compiled by TIME Magazine in collaboration with data and research firm Statista.

18 March 2026

medmix Full-Year 2025 Results

Ad hoc announcement pursuant to Art. 53 LR

Resilient Performance with Strong Profit Gains in Challenging Markets

26 February 2026

medmix’ Drug Delivery (“Haselmeier”) highlights self-injection PiccoJect™ platform as innovation for high-viscosity drugs

medmix’ Drug Delivery (“Haselmeier”) showcased the proven innovation behind its PiccoJect™ platform for high-viscosity drugs at the international conferences PDA Universe in Vienna and PODD in Boston.

20 November 2025

medmix wins one of the largest new Beauty businesses in company history and strengthens position in key global beauty markets with facility extensions

medmix wins one of the largest new Beauty businesses in company history and strengthens position in key global beauty markets with facility extensions

8 October 2025